Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

On November 9, 2021 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, reported that management will be participating in the following investor conferences (Press release, Sangamo Therapeutics, NOV 9, 2021, View Source [SID1234594987]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Gene Editing & Gene Therapy Summit
Date: Monday, November 15th at 10:30 a.m. Eastern Time
Stifel 2021 Virtual Healthcare Conference
Date: Monday, November 15th at 3:20 p.m. Eastern Time
Jefferies London Healthcare Conference
Date: Tuesday, November 16th at 8:40 a.m. Eastern Time
For presentations and fireside chats that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.